Komori
Medinet (2370) · InitiativeAdvanced

Issuance of New Shares as Restricted Stock Compensation

First written in FY2023-Q1. 4 of 5 entries say "Advanced", first in FY2023. Latest entry: 2026-05-13.

5entries
4years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023-Q1AdvancedFY2023 – 2026-05-132023: 220232024: 120242025: 120252026: 12026
Same theme, other companies
Grant and Issuance of Equity Compensation to Employees and Officers (Stock Options and Restricted Stock)A theme 659 companies write about · 0 as a headwind · 740 as a tailwind

106 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 179 companies compared. The sentences above are computed from all 179.Comparing 200 of the theme's 742 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-05-13AdvancedEarnings

    「On 16 February 2026, we issued new shares as restricted stock compensation for directors and as stock compensation under a restricted stock unit grant plan for employees.」

    New shares were issued as stock-based compensation for directors and employees, resulting in increases of ¥13 million each in stated capital and capital surplus.
  2. FY2025-H1AdvancedAnnual report

    「Effective 17 February 2025, the company issued new shares as restricted stock compensation. As a result, capital stock and capital surplus each increased by ¥3.85 million.」

    As restricted stock compensation, the company issued 213,892 common shares on 17 February 2025, increasing capital stock and capital surplus by ¥3.85 million each.
  3. FY2024-Q1AdvancedAnnual report

    「On 10 January 2024, the company issued new shares as restricted stock compensation. The details are as follows. ① Class and number of shares issued: common shares, 179,549 shares ② Issue price: ¥44 per share ③ Total issue price: ¥7.9 million ④ Increase in capital stock: ¥3.95 million ⑤ Increase in capital reserve: ¥3.95 million」

    As restricted stock compensation, the company issued 179,549 common shares on 10 January 2024, for a total issue price of ¥7.9 million, increasing capital stock and capital reserve by ¥3.95 million each.
  4. FY2023AdvancedAnnual report

    「On 1 February 2023, the company issued new shares as restricted stock compensation.」

    The company issued 105,334 common shares as restricted stock compensation, for a total issue price of ¥7.9 million, increasing capital stock and capital reserve by ¥3.95 million each. The ratio of fixed compensation to stock-based compensation for directors is set at approximately 9:1.
  5. FY2023-Q1First statedAnnual report

    「On 1 February 2023, we issued new shares as restricted stock compensation. The details were as follows: 1. Type and number of shares issued: common shares, 105,334 shares; 2. Issue price: ¥75 per share; 3. Total issue price: ¥7,900 thousand.」

    The Company issued 105,334 common shares at ¥75 per share as restricted stock compensation on 1 February 2023, increasing share capital and capital reserve by ¥3,950 thousand each.
Moved together

"Commercialization of the Contract Cell-Processing Business" moved the same way as this thread, in the same document, in 4 of its 5 moves.

444322★123456
  1. ★This thread
  2. 1Commercialization of the Contract Cell-Processing Business4×
  3. 2Financing Through Third-Party Allotments, Convertible Bonds and Stock Acquisition Rights4×
  4. 3Revenue Growth Including Income from New Businesses4×
  5. 4Risk of Insufficient Financing Due to Unexercised Stock Acquisition Rights3×
  6. 5Decline in Patient Numbers at Contract Medical Institutions2×
  7. 6Deficit Offset Through Capital Reduction Without Compensation and Transfer of Surplus2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Medinet yet. It last moved in the Earnings of 2026-05-13: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.